<DOC>
	<DOCNO>NCT01343355</DOCNO>
	<brief_summary>An open-label , non-randomised , uncontrolled , proof-of-concept study patient HTLV-I-associated myelopathy/Tropical Spastic Paraparesis ( HAM/TSP ) . Participants receive oral administration tamibarotene amount 2 mg daily period 12 week , 4mg daily another 12 week . The patient follow 8 week . Efficacy monitor measure clinical score include motor urination function , HTLV-1 proviral load , immunological parameter , marker spinal fluid . Safety evaluate time .</brief_summary>
	<brief_title>Efficacy Safety Tamibarotene ( AM80H ) HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis ( HAM/TSP )</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Spinal Cord Diseases</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<mesh_term>Paraparesis</mesh_term>
	<mesh_term>Paraparesis , Spastic</mesh_term>
	<mesh_term>Paraparesis , Tropical Spastic</mesh_term>
	<criteria>Patients diagnose HAM accord WHO criteria Patients positive HTLVI antibody spinal fluid Patients , female , pregnant breastfeeding , either agree take contraceptive measure two year treatment , sterile Patients , male , agree take contraceptive measure six month treatment Patients inform understood content study consent participate sign form . Patients rapid progress symptom define increase two Osame 's Motor Disability Score HAM patient past one year . Patients hyperlipidemia ( serum triglyceride high 400 mg/dL ) Patients administer new increase dose corticosteroid past 8 week intervention Patients receive steroid pulse therapy past 8 week intervention Patients administer new increase dose immunosuppressant past 8 week intervention Patients history serious drug allergy Patients significant complication malignancy , severe heart failure , serious disease . Patients past administered etretinate .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Tropical Spastic Paraparesis</keyword>
	<keyword>HAM</keyword>
	<keyword>TSP</keyword>
</DOC>